CMSAR23088 // EA7211 // Victor
Basic Study Information
Purpose:
This is a multicenter, randomized, open label phase lll trial to assess whether preoperative
chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of
high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as
measured by disease free survival.
After confirmation of eligibility criteria, patients will be randomized to either
the standard arm or experimental arm.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Adrienne Victor
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search